Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.21
+0.09 (1.11%)
At close: Feb 27, 2026, 4:00 PM EST
8.21
0.00 (-0.03%)
After-hours: Feb 27, 2026, 7:37 PM EST
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $469.03 million as of February 27, 2026. Its market cap has increased by 308.44% in one year.
Market Cap
469.03M
Enterprise Value
302.92M
1-Year Change
308.44%
Ranking
Category
Stock Price
$8.21
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $469.03M, a decrease of -47.77%. That is a compound annual growth rate of -27.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 469.03M | -12.66% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rocket Pharmaceuticals | 474.01M |
| vTv Therapeutics | 471.79M |
| Prothena Corporation | 465.09M |
| Lineage Cell Therapeutics | 462.85M |
| Assembly Biosciences | 462.49M |
| Autolus Therapeutics | 455.11M |
| Immix Biopharma | 449.49M |
| Keros Therapeutics | 447.70M |